MarketInOut Stock Screener Log In | Sign Up

Pulse Biosciences Inc

NASDAQ • Healthcare • Medical Instruments & Supplies • Quote as of 10/30/2026
Pulse Biosciences Inc stock price and volume chart

Company Profile

IndustryMedical Instruments & Supplies
SectorHealthcare
ExchangeNASDAQ
Market Capitalization3,879.95 mln
Float22.03 mln
Earnings Date11/05/2026

Piotroski F-Score

5 / 9
Neutral

1-Year Forecast

62.33
Attractive

Relative Strength

96 / 100
Top performer

Debt / Equity

0.07
Debt-free

Pre-Tax Margin

-6,756%
Severely loss-making

ROE

-90.23
Deeply negative

Business Description

Pulse Biosciences is a medical technology company founded in 2014 and based in Miami, Florida. The company develops energy-based treatment systems that use ultra-short electrical pulses to destroy unwanted tissue in the body, with applications ranging from skin conditions to heart rhythm disorders. Its product line includes tools for use in both surgical and clinical settings, giving physicians flexible options for different treatment needs.

Key Fundamentals

EPS-1.18
ROE-90.23
RPS0.02
ROIC-519
ROA-76.64
EBITDA, mln-79.03
EV / EBITDA-47.18
EV / EBIT-46.57
Revenue, mln1.18
EV / Revenue3,146

Quote Details

Last 52.24
Change -3.24 (-5.84%)
Open 54.33
Volume 466,045
Turnover 24,346,192
Average Volume 388,537

Financial Ratios

Pre-Tax Profit Margin-6,756
Leverage Ratio1.16
Current Ratio9.63
Price / Book37.73
Price / Tangible Book39.12
Debt / Equity0.07
Price / Sales3,129

Financial Strength

Altman Z-Score136
Piotroski F-Score 5 / 9
1-Year Target Price62.33
Short Ratio5.88
Short % of Float14.09

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -1.47% 33 / 100   
1 Month 4.84% 85 / 100   
2 Months 59.32% 98 / 100   
6 Months 151% 99 / 100   
1 Year 205% 99 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog